A detailed history of Bell Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bell Bank holds 29,120 shares of BMY stock, worth $1.68 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
29,120
Previous 28,862 0.89%
Holding current value
$1.68 Million
Previous $1.2 Million 25.71%
% of portfolio
0.18%
Previous 0.1%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$39.66 - $51.75 $10,232 - $13,351
258 Added 0.89%
29,120 $1.51 Million
Q2 2024

Jul 31, 2024

BUY
$40.25 - $52.99 $93,943 - $123,678
2,334 Added 8.8%
28,862 $1.2 Million
Q1 2024

Apr 23, 2024

BUY
$47.98 - $54.4 $93,944 - $106,515
1,958 Added 7.97%
26,528 $1.44 Million
Q4 2023

Jan 22, 2024

BUY
$48.48 - $57.85 $47,752 - $56,982
985 Added 4.18%
24,570 $1.26 Million
Q3 2023

Oct 30, 2023

BUY
$57.89 - $64.73 $67,557 - $75,539
1,167 Added 5.21%
23,585 $1.37 Million
Q2 2023

Jul 26, 2023

BUY
$63.71 - $70.74 $180,108 - $199,981
2,827 Added 14.43%
22,418 $1.43 Million
Q1 2023

Apr 19, 2023

BUY
$65.71 - $74.53 $3,548 - $4,024
54 Added 0.28%
19,591 $1.36 Million
Q4 2022

Jan 31, 2023

SELL
$68.48 - $81.09 $20,133 - $23,840
-294 Reduced 1.48%
19,537 $1.41 Million
Q3 2022

Oct 11, 2022

SELL
$0.13 - $76.84 $143 - $84,524
-1,100 Reduced 5.26%
19,831 $1.41 Million
Q2 2022

Jul 15, 2022

BUY
$72.62 - $79.98 $110,309 - $121,489
1,519 Added 7.83%
20,931 $1.61 Million
Q1 2021

May 07, 2021

SELL
$59.34 - $66.74 $23,736 - $26,695
-400 Reduced 2.02%
19,412 $1.23 Million
Q4 2020

Feb 05, 2021

BUY
$57.74 - $65.43 $23,096 - $26,172
400 Added 2.06%
19,812 $1.23 Million
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $145,710 - $190,066
2,961 Added 18.0%
19,412 $1.25 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $6,648 - $7,351
-149 Reduced 0.9%
16,451 $746,000
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $31,944 - $38,090
-708 Reduced 4.09%
16,600 $792,000
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $34,375 - $44,577
705 Added 4.25%
17,308 $900,000
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $827,850 - $933,750
-15,000 Reduced 47.46%
16,603 $1.03 Million
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $34,158 - $42,574
676 Added 2.19%
31,603 $1.75 Million
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $3,296 - $3,594
-55 Reduced 0.18%
30,927 $1.9 Million
Q3 2017

Nov 13, 2017

SELL
$55.23 - $63.74 $773 - $892
-14 Reduced 0.05%
30,982 $1.98 Million
Q2 2017

Aug 14, 2017

BUY
N/A
30,996
30,996 $1.73 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Bell Bank Portfolio

Follow Bell Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Bank, based on Form 13F filings with the SEC.

News

Stay updated on Bell Bank with notifications on news.